Literature DB >> 10601979

Activation of the mouse oxytocin promoter by the orphan receptor RORalpha.

K Chu1, H H Zingg.   

Abstract

Although an increasing number of nuclear orphan receptors have recently been identified, the number of known naturally occurring genes that are directly regulated by orphan receptors is still small. We have shown previously that the gene encoding the neuropeptide oxytocin (OT) is negatively regulated by the orphan receptors chicken ovalbumin upstream transcription factor I (COUP-TFI) and II. Here we show that the mouse OT gene promoter is activated by RORalpha, a representative of the ROR/RZR orphan receptor subfamily. Using promoter/chloramphenicol acetyltransferase reporter constructs in heterologous transfection assays, we determined that RORalpha action induces a <6-fold increase in promoter activity. By 5' and 3' deletion analysis, DNase footprint analysis and electrophoretic mobility shift assays, we found that RORalpha action is mediated by two 14 bp regions centered at 160 and 180 nucleotides upstream of the transcriptional initiation site. Both sites contain significant sequence identities with an established ROR recognition sequence. Mutations in either or both of these sites reduce significantly RORalpha-induced activation of the OT promoter. In view of the strong transcriptional activation exerted by RORalpha on the OT gene promoter and the widespread distribution of different members of the ROR/RZR family, interactions between ROR/RZR isoforms and the OT gene may form part of the multifactorial regulatory mechanisms that control OT gene expression in different tissues.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10601979     DOI: 10.1677/jme.0.0230337

Source DB:  PubMed          Journal:  J Mol Endocrinol        ISSN: 0952-5041            Impact factor:   5.098


  8 in total

1.  Cell-type specific oxytocin gene expression from AAV delivered promoter deletion constructs into the rat supraoptic nucleus in vivo.

Authors:  Raymond L Fields; Todd A Ponzio; Makoto Kawasaki; Harold Gainer
Journal:  PLoS One       Date:  2012-02-21       Impact factor: 3.240

Review 2.  Cell-type specific expression of oxytocin and vasopressin genes: an experimental odyssey.

Authors:  H Gainer
Journal:  J Neuroendocrinol       Date:  2012-04       Impact factor: 3.627

3.  Retinoid-related receptor (ROR) alpha mRNA expression is altered in the brain of male mice lacking all ligand-binding thyroid hormone receptor (TR) isoforms.

Authors:  Nandini Vasudevan; Hosein Kami Kia; Maria Hadjimarkou; Noriyuki Koibuchi; William W Chin; Douglas Forrest; Bjorn Vennstrom; Donald Pfaff
Journal:  Endocrine       Date:  2005-02       Impact factor: 3.633

4.  Optogenetic approaches to characterize the long-range synaptic pathways from the hypothalamus to brain stem autonomic nuclei.

Authors:  Ramón A Piñol; Ryan Bateman; David Mendelowitz
Journal:  J Neurosci Methods       Date:  2012-08-07       Impact factor: 2.390

5.  Requirement of the orphan nuclear receptor SF-1 in terminal differentiation of ventromedial hypothalamic neurons.

Authors:  Phu V Tran; Martin B Lee; Oscar Marín; Baoji Xu; Kevin R Jones; Louis F Reichardt; John R Rubenstein; Holly A Ingraham
Journal:  Mol Cell Neurosci       Date:  2003-04       Impact factor: 4.314

6.  Retinoid-related Orphan Receptors (RORs): Roles in Cellular Differentiation and Development.

Authors:  Anton M Jetten; Joung Hyuck Joo
Journal:  Adv Dev Biol       Date:  2006

7.  A role for the androgen metabolite, 5alpha androstane 3beta, 17beta diol (3β-diol) in the regulation of the hypothalamo-pituitary-adrenal axis.

Authors:  Robert J Handa; Dharmendra Sharma; Rosalie Uht
Journal:  Front Endocrinol (Lausanne)       Date:  2011-11-10       Impact factor: 5.555

8.  Analysis of transcription factor mRNAs in identified oxytocin and vasopressin magnocellular neurons isolated by laser capture microdissection.

Authors:  Madison Humerick; Jeffrey Hanson; Jaime Rodriguez-Canales; Daniel Lubelski; Omar M Rashid; Yasmmyn D Salinas; Yijun Shi; Todd Ponzio; Raymond Fields; Michael R Emmert-Buck; Harold Gainer
Journal:  PLoS One       Date:  2013-07-24       Impact factor: 3.240

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.